Ovarian cellular fibromas lack FOXL2 mutations a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor

American Journal of Surgical Pathology

Volumn 37, Issue 9, 2013, Pages 1450-1455

  McCluggage, W Glenn ^a   Singh, Naveena ^b   Kommoss, Stefan ^c   Huntsman, David G ^c   Gilks, C Blake ^d,e  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c Centre for Translational and Applied Genomics   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Adult granulosa cell tumor; Cellular fibroma; FOXL2 mutation; Ovary

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXL2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CHEMISTRY; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMA; GENETIC PREDISPOSITION; GENETICS; GRANULOSA CELL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MITOSIS; MUTATION; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROMA; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; GRANULOSA CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MITOSIS; MUTATION; OVARIAN NEOPLASMS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884532414     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31828e4f55     Document Type: Article

References (14)

1. Irving JA, Alkushi A, Young RH, et al. Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol. 2006;30:929-938.
2. Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosacell tumors of the ovary. N Engl J Med. 2009;25:2719-2729.
3. Kim T, Sung CO, Song SY, et al. FOXL2 mutation in granulosa-cell tumours of the ovary. Histopathology. 2010;56:408-410.
4. Jamieson S, Butzow R, Andersson N, et al. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Mod Pathol. 2010;23:1477-1485.
5. D'Angelo E, Mozos A, Nakayama D, et al. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary. Mod Pathol. 2011;24:1360-1367.
6. Kim MS, Hur SY, Yoo NJ, et al. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol. 2010;221:147-152.
7. Kobel M, Gilks CB, Huntsman DG. Adult-type granulosa cell tumors and FOXL2 mutation. Cancer Res. 2009;69:9160-9162.
8. Al-Agha OM, Huwait HF, Chow C, et al. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol. 2011;35:484-494.
9. Kommoss S, Anglesio M, Mackenzie R, et al. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod Pathol. 2013. [Epub ahead of print].
10. Scully RE, Young RH, Clement PB. Sex cord-stromal tumors, granulosa cell tumors. In: Scully RE, Young RH, Clement PB, eds. Atlas of Tumor Pathology. Tumors of the Ovary, Maldeveloped gonads, Fallopian Tube and Broad Ligament. Washington, DC: Armed Forces Institute of Pathology; 1996:169-188.
11. Bucella D, Limbosch JF, Buxant F, et al. Recurrence of mitotically active cellular fibroma of the ovary. Obstet Gynecol Int. 2009; 2009:803062.
12. Oparka R, Cassidy A, Reilly S, et al. The C134W (402 CG) FOXL2 mutation is absent in ovarian gynandroblastoma: insights into the genesis of an unusual tumour. Histopathology. 2012;60: 838-842.
13. Hes O, Vane?c?ek T, Petersson F, et al. Mutational analysis (c. 402CG) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors. Appl Immunohistochem Mol Morphol. 2011;19:347-351.
14. Lima JF, Jin L, de Araujo AR, et al. FOXL2 mutations in granulosa cell tumors occurring in males. Arch Pathol Lab Med. 2012;136: 825-828.